Gadolinium Gd · 64

A rare earth that absorbs neutrons better than almost anything, and that makes MRI scans easier to read.

Warum ist das wichtig?

It does two unrelated critical jobs: control rods and burnable poison in nuclear reactors, and contrast agent in medical imaging.

Where it is in the Earth

Gadolinium is one of the heavy rare earth elements (HREEs), a group that sits toward the higher end of the lanthanide series. Unlike the light rare earths — lanthanum, cerium, neodymium — which tend to concentrate in hard-rock carbonate minerals such as bastnäsite, the heavy rare earths including gadolinium behave differently in geological processes. Because their ionic radius is smaller and their charge density higher, they are less readily incorporated into the common phosphate and carbonate minerals that crystallise early from a cooling magma. Instead, they tend either to accumulate late in the life of a granite intrusion, appearing in accessory minerals such as xenotime (yttrium phosphate, which accepts gadolinium as a chemical stand-in for yttrium), or to remain mobile in groundwater long after the original rock has formed.

The second and now dominant geological setting is what gives the southern Chinese deposits their character. When a granite rich in rare earth elements weathers slowly over millions of years in a warm, humid climate, the rock breaks down to clay minerals — chiefly kaolinite. Rare earth ions released during that weathering do not wash away entirely; instead they adsorb, meaning they attach loosely to the surfaces of the clay particles, held by electrostatic attraction. These are called ion-adsorption clay deposits, and they are unusual because the rare earth content is not locked inside a hard mineral crystal but simply sitting on the clay surface. Heavy rare earths, including gadolinium, are proportionally more abundant in these clays than in hard-rock deposits, which is why the ion-adsorption clays of Jiangxi and neighbouring provinces became the world's principal source. The deposits themselves are not deep — they follow the weathering profile of the granite beneath, typically in hillsides and low mountains — and they carry no dramatic visual signature; the ore looks like ordinary pale clay.

Xenotime, the phosphate mineral listed in the ore table, matters as a secondary source. It crystallises in granites and pegmatites (coarse-grained, late-stage igneous rocks) and also concentrates in placer deposits — accumulations of dense, resistant minerals in river sands and beach sands — because it is physically tough and does not dissolve easily. Monazite, a related rare earth phosphate, appears in many of the same placers and carries some gadolinium as well, though it is a richer source of lighter rare earths such as lanthanum and cerium. The relative scarcity of dedicated gadolinium-bearing hard-rock orebodies, compared with the ubiquity of light rare earth deposits, is a direct consequence of this geochemistry: gadolinium simply does not accumulate to high concentrations in the minerals that form the most common and largest rare earth deposits outside China.

Getting it out

The ore table shows two main sources: ion-adsorption clays mined by in-situ leaching in southern China, and xenotime recovered from hard-rock or placer mining elsewhere. In-situ leaching is a method quite different from conventional mining. Rather than digging the ore out of the ground, operators drill an array of injection wells into the clay-bearing hillside and pump a dilute salt solution — historically ammonium sulfate, though regulations have pushed toward lower-impact reagents — down into the deposit. Because the rare earth ions are only loosely adsorbed onto the clay surface rather than locked inside a mineral crystal, the salt ions in the solution displace them by ion exchange, and the rare earth-bearing solution drains to collection points at the base of the slope. The disturbed ground is the hillside itself rather than a large open pit, but the environmental footprint is not trivial: the leaching solution alters soil chemistry, and if collection is imperfect, rare earths and reagents can migrate into local waterways.

What the grade figures mean in practice is worth understanding. Ion-adsorption clay deposits carry rare earth concentrations that are low by the standards of hard-rock mining, often measured in hundreds of grams per tonne of total rare earth oxide. In a conventional mine, moving that grade of material would rarely be economic. In-situ leaching changes the economics because there is no blasting, no haulage of waste rock, and no milling of ore — the solution does the extraction work underground, and the volumes of liquid handled, though large, cost less to process than crushed rock. The trade-off is that recovery of the rare earth from the clay is incomplete, and the clay structure of the hillside is permanently changed.

Xenotime recovered from placer operations — river or beach sand deposits in countries such as Malaysia and Australia — reaches the supply chain mostly as a by-product of mining for other heavy minerals such as ilmenite, rutile, or zircon. In that context, the amount of gadolinium-bearing xenotime produced depends more on the market for those primary commodities than on demand for rare earths. This by-product nature limits how quickly supply from these sources can respond to changing conditions.

What pulls on it

The end-market table records two principal uses: MRI contrast agents in medicine, and burnable neutron poison in nuclear reactor fuel. These two applications are largely independent of each other in their growth drivers, which gives gadolinium a demand profile that is not hostage to any single industry. In medical imaging, gadolinium-based contrast agents are injected into patients before certain magnetic resonance imaging scans. The gadolinium ion is strongly paramagnetic — meaning it is drawn into a magnetic field and distorts the local magnetic environment — and this property alters the signal returned by hydrogen atoms in surrounding tissue, making features such as tumours, inflammation, or blood vessels easier to distinguish. The agents cannot simply be gadolinium salts; free gadolinium ions are toxic, so the metal must be enclosed in a chelate molecule that the body can excrete. Demand from this sector is tied to the global installed base of MRI machines and the volume of contrast-enhanced scans performed, both of which have grown as healthcare systems in middle-income countries expand their diagnostic capacity.

In nuclear reactors, gadolinium serves a different purpose entirely. Certain gadolinium isotopes absorb neutrons with exceptional efficiency — the relevant term is a very high neutron-absorption cross-section. When gadolinium oxide is blended into uranium fuel pellets, it acts as a burnable poison: it suppresses the fission reaction at the start of the fuel cycle when the uranium is freshest and the reactor would otherwise be difficult to control, then it is gradually consumed by neutron absorption so that by mid-cycle most of it is gone and the full fuel load is available. This is a more sophisticated control approach than relying solely on moveable control rods. Demand from this sector is tied to the number of reactors loading gadolinium-doped fuel assemblies and the frequency of fuel cycles, both of which vary with nuclear power policy globally.

A smaller but non-trivial use mentioned in the USGS data is metallurgy, where gadolinium is added in small quantities to iron and chromium alloys to improve their workability and resistance to high-temperature oxidation. Permanent magnet applications also appear, though gadolinium does not carry the same importance in that sector that neodymium or dysprosium does. For demand to shift sharply upward, a significant expansion of nuclear power programmes using gadolinium-doped fuel, or a substantial increase in MRI scan volumes in currently underserved populations, would both move the needle. A shift downward could result from regulatory changes affecting gadolinium-based contrast agents — and there have been periodic reviews of their safety profile, particularly regarding gadolinium retention in tissues — or from reactor designs that rely less on burnable poisons.